AstraZeneca's (AZN) “Buy” Rating Reaffirmed at Barclays - Defense World

Retrieved on: 2023-11-21 14:55:58

Tags for this article:

Medical research

AstraZeneca

Södertälje Municipality

Oxford–AstraZeneca COVID-19 vaccine

AZN

Price?earnings ratio

AstraZeneca plc

Click the tags to see associated articles and topics

AstraZeneca's (AZN) “Buy” Rating Reaffirmed at Barclays - Defense World. View article details on HISWAI: https://www.defenseworld.net/2023/11/21/astrazenecas-azn-buy-rating-reaffirmed-at-barclays.html

Excerpt

Other equities analysts have also issued research reports about the company. Citigroup reissued a buy rating on shares of AstraZeneca in a research ...

Article found on: www.defenseworld.net

View Original Article